Skip to main content

Table 1 Data and clinical details of patients and normal people recruited in this study

From: Increasing substance P levels in serum and synovial tissues from patients with developmental dysplasia of the hip (DDH)

 

DDH&OA

DDH

Normal

Number

45

56

31

Ages (yrs)

40.4 ± 5.3 (35-48)

28.5 ± 6.4 (21-34)

33 ± 4.5 (22-38)

Female/Male

31/14

48/12

17/14

BMI (kg/m2)

23.5 ± 1.3

22.7 ± 0.8

22.2 ± 1.1

Durations (yrs)

3.8 ± 0.5

1.3 ± 0.4

—

CRP (mg/l)

8.4 ± 2.4*Δ

4.7 ± 1.5

2.4 ± 0.7

ESR (mm/1st h)

16.8 ± 4.6*

12.3 ± 3.6*

6.2 ± 1.6

Harris hip score

37 ± 6.4**#

75.7 ± 8.3*

96 ± 2.5

Visual analogue score

5.7 ± 2.4Δ

3.2 ± 1.8

—

Synovial sample

35/45

20/56

—

Blood sample

40/45

40/56

31

  1. BMI Body mass index, CRP C-reactive protein, ESR Erythrocyte sedimentation rate. Data are given as mean ± standard deviation (SD). *P < 0.05 and **P < 0.01 compared to data in normal group. ΔP < 0.05 and #P < 0.01 compared to data in DDH group.